KYTHERA BIOPHARMACEUTICALS INC 4
4 · KYTHERA BIOPHARMACEUTICALS INC · Filed Oct 2, 2015
Insider Transaction Report
Form 4Exit
RENTON HOLLINGS
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
[F1]2015-10-01−18,000→ 0 totalExercise: $34.68Exp: 2024-12-31→ Common Stock (18,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
[F1]2015-10-01−11,591→ 0 totalExercise: $53.26Exp: 2025-06-02→ Common Stock (11,591 underlying)
Footnotes (1)
- [F1]Disposed of pursuant to the Amended and Restated Agreement and Plan of Merger dated as of August 4, 2015, by and among Allergan plc (formerly known as Actavis plc) ("Allergan"), Keto Merger Sub, Inc. (a wholly owned subsidiary of Allergan) and Issuer, whereby each option to purchase common stock was cancelled and paid in cash assuming a stock price of $75.00.
Signature
/s/ Keith Klein, as Attorney-in-Fact for Hollings C. Renton, III|2015-10-02